4//SEC Filing
MURPHY JOHN RAYMOND 4
Accession 0001213900-23-022065
CIK 0001937993other
Filed
Mar 21, 8:00 PM ET
Accepted
Mar 22, 4:01 PM ET
Size
4.9 KB
Accession
0001213900-23-022065
Insider Transaction Report
Form 4
MURPHY JOHN RAYMOND
Director
Transactions
- Purchase
Common Stock
2023-03-21$1.39/sh+10,000$13,900→ 594,792 total
Footnotes (1)
- [F1]The amount of securities beneficially owned by Mr. Murphy following the reported transaction is correctly reported on this Form 4. The amount of securities beneficially owned by Mr. Murphy has been adjusted to correct immaterial errors in prior Form 4 filings that were filed with the Securities and Exchange Commission on January 24, 2023 and March 16, 2023.
Documents
Issuer
Cadrenal Therapeutics, Inc.
CIK 0001937993
Entity typeother
Related Parties
1- filerCIK 0001275195
Filing Metadata
- Form type
- 4
- Filed
- Mar 21, 8:00 PM ET
- Accepted
- Mar 22, 4:01 PM ET
- Size
- 4.9 KB